Ebbing Lautenbach - Publications

Affiliations: 
Epidemiology and Biostatistics University of Pennsylvania, Philadelphia, PA, United States 
Area:
Epidemiology, Microbiology Biology

211 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhang HL, Perez R, Krishnan J, Lautenbach E, Anderson DJ. Risk Factors for Recurrence of Community-Onset Urinary Tract Infections Caused by Extended-Spectrum Cephalosporin-Resistant Enterobacterales. Open Forum Infectious Diseases. 10: ofad561. PMID 38130594 DOI: 10.1093/ofid/ofad561  0.318
2023 Lautenbach E, Mosepele M, Smith RM, Styczynski A, Gross R, Cressman L, Jaskowiak-Barr A, Alby K, Glaser L, Richard-Greenblatt M, Cowden L, Sewawa K, Otukile D, Paganotti GM, Mokomane M, et al. Risk Factors for Community Colonization With Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 77: S89-S96. PMID 37406040 DOI: 10.1093/cid/ciad259  0.364
2022 Zhang HL, Han JH, Lapp Z, Snitkin E, Goldstein EJC, Muldoon S, Tolomeo P, Lautenbach E. Risk Factors for Colistin-Resistant Carbapenem-Resistant in the Postacute Care Setting. Open Forum Infectious Diseases. 9: ofac452. PMID 36168553 DOI: 10.1093/ofid/ofac452  0.311
2022 Zhang HL, Gontjes KJ, Han JH, Alby K, Lapp Z, Snitkin E, Goldstein EJC, Muldoon S, Tolomeo P, Lautenbach E. Characterization of resistance to newer antimicrobials among carbapenem-resistant in the post-acute-care setting. Infection Control and Hospital Epidemiology. 1-4. PMID 35896514 DOI: 10.1017/ice.2022.185  0.303
2022 Mannathoko N, Mospele M, Gross R, Smith RM, Alby K, Glaser L, Richard-Greenblatt M, Dumm R, Sharma A, Jaskowiak-Barr A, Cressman L, Sewawa K, Cowden L, Reesey E, Otukile D, ... ... Lautenbach E, et al. Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 35688308 DOI: 10.1016/j.ijid.2022.06.004  0.308
2022 Ferradas C, Cotter C, Shahbazian JH, Iverson SA, Baron P, Misic AM, Brazil AM, Rankin SC, Nachamkin I, Ferguson JM, Peng RD, Bilker WB, Lautenbach E, Morris DO, Lescano AG, et al. Risk factors for antimicrobial resistance among Staphylococcus isolated from pets living with a patient diagnosed with methicillin-resistant Staphylococcus aureus infection. Zoonoses and Public Health. PMID 35420715 DOI: 10.1111/zph.12946  0.356
2021 Zhang HL, Cressman L, Lautenbach E. Real-world clinical outcomes of meropenem/vaborbactam for treatment of carbapenem-resistant Enterobacterales infections. Journal of Global Antimicrobial Resistance. 27: 299-302. PMID 34775130 DOI: 10.1016/j.jgar.2021.09.015  0.308
2021 Kelly BJ, Bekele S, Loughrey S, Huang E, Tolomeo P, David MZ, Lautenbach E, Han JH, Ziegler MJ. Healthcare microenvironments define multidrug-resistant organism persistence. Infection Control and Hospital Epidemiology. 1-7. PMID 34425925 DOI: 10.1017/ice.2021.323  0.344
2021 Lapp Z, Han JH, Wiens J, Goldstein EJC, Lautenbach E, Snitkin ES. Patient and Microbial Genomic Factors Associated with Carbapenem-Resistant Klebsiella pneumoniae Extraintestinal Colonization and Infection. Msystems. 6. PMID 33727393 DOI: 10.1128/mSystems.00177-21  0.349
2021 Nelson RE, Lautenbach E, Chang N, Jones M, Willson T, David M, Linkin D, Glick H, Doshi JA, Stevens VW. Attributable Cost of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infection in a Long-term Care Center. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 72: S27-S33. PMID 33512522 DOI: 10.1093/cid/ciaa1582  0.312
2020 Cawcutt KA, Patel R, Gerber J, Caliendo AM, Cosgrove SE, Ashley ED, Garzaro P, Miller M, Lautenbach E. Leveraging Existing and Soon-to-Be-Available Novel Diagnostics for Optimizing Outpatient Antibiotic Stewardship in Patients with Respiratory Tract Infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33277647 DOI: 10.1093/cid/ciaa1815  0.334
2020 Szymczak JE, Muller BM, Shakamuri NS, Hamilton KW, Gerber JS, Laguio-Vila M, Dumyati GK, Fridkin SK, Guh AY, Reddy SC, Lautenbach E. Prescriber perceptions of fluoroquinolones, extended-spectrum cephalosporins, and infection. Infection Control and Hospital Epidemiology. 1-7. PMID 32468967 DOI: 10.1017/Ice.2020.183  0.422
2020 Anesi JA, Lautenbach E, Tamma PD, Thom KA, Blumberg EA, Alby K, Bilker WB, Werzen A, Tolomeo P, Omorogbe J, Pineles L, Han JH. Risk factors for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infection among solid organ transplant recipients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32149327 DOI: 10.1093/Cid/Ciaa190  0.35
2020 Amoah J, Stuart EA, Cosgrove SE, Harris AD, Han JH, Lautenbach E, Tamma PD. Comparing Propensity Score Methods versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32069360 DOI: 10.1093/Cid/Ciaa169  0.307
2020 Redding LE, Kelly BJ, Stefanovski D, Lautenbach JK, Tolomeo P, Cressman L, Gruber E, Meily P, Lautenbach E. Pet Ownership Protects Against Recurrence of Infection. Open Forum Infectious Diseases. 7: ofz541. PMID 31976354 DOI: 10.1093/Ofid/Ofz541  0.392
2019 Han JH, Lapp Z, Bushman F, Lautenbach E, Goldstein EJC, Mattei L, Hofstaedter CE, Kim D, Nachamkin I, Garrigan C, Jain T, Bilker W, Wolford HM, Slayton RB, Wise J, et al. Whole Genome Sequencing to Identify Drivers of Carbapenem-Resistant Transmission Within and Between Regional Long-Term Acute Care Hospitals. Antimicrobial Agents and Chemotherapy. PMID 31451495 DOI: 10.1128/Aac.01622-19  0.405
2019 Anesi JA, Blumberg EA, Han JH, Lee DH, Clauss H, Climaco A, Hasz R, Molnar E, Alimenti D, West S, Bilker WB, Tolomeo P, Lautenbach E. Risk factors for multidrug-resistant organisms among deceased organ donors. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 31162785 DOI: 10.1111/Ajt.15488  0.342
2019 Dutcher L, Lautenbach E. A deeper dive: Implications of identifying more of the Carbapenem-resistant Enterobacteriaceae Iceberg. The Journal of Infectious Diseases. PMID 31150533 DOI: 10.1093/Infdis/Jiz290  0.392
2019 Weinstein EJ, Han JH, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Dankwa L, Wheeler M, Tolomeo P, Anesi JA. A Clinical Prediction Tool for Extended-Spectrum Cephalosporin Resistance in Community-Onset Enterobacterales Urinary Tract Infection. Open Forum Infectious Diseases. 6: ofz164. PMID 31041359 DOI: 10.1093/Ofid/Ofz164  0.425
2019 Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheeler M, Tolomeo P, Han JH. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study. Bmc Infectious Diseases. 19: 163. PMID 30764770 DOI: 10.1186/S12879-019-3804-Y  0.453
2019 Tamma PD, Conley AT, Cosgrove SE, Harris AD, Lautenbach E, Amoah J, Avdic E, Tolomeo P, Wise J, Subudhi S, Han JH. Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia. Jama Internal Medicine. PMID 30667477 DOI: 10.1001/Jamainternmed.2018.6226  0.317
2019 Laguio-Vila MR, Staicu ML, Brundige ML, Alcantara-Contreras J, Yang H, Lautenbach E, Dumyati G. 1115. Reducing Broad-Spectrum Antibiotics for Uncomplicated Urinary Tract Infections: A Multimodal Stewardship Intervention Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.979  0.374
2019 Anesi JA, Blumberg E, Han J, Lee DH, Clauss H, Climaco A, Hasz R, Molnar E, Alimenti D, West S, Bilker W, Tolomeo PC, Lautenbach E. 2657. Clinical Prediction Tool for Multidrug-Resistant Organisms Among Deceased Donors at the Time of Donor Evaluation Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.2335  0.32
2019 Dutcher LS, Degnan K, Lautenbach E, Pegues DA, David MZ, Cluzet V, Cressman L, Bilker W, Tolomeo PC, Adu-Gyamfi AB, Hamilton KW. 2067. Improving Outpatient Antimicrobial Prescribing for Respiratory Tract Infections Open Forum Infectious Diseases. 6: S696-S697. DOI: 10.1093/Ofid/Ofz360.1747  0.369
2018 Downes KJ, Fitzgerald JC, Schriver E, Boge CLK, Russo ME, Weiss SL, Balamuth F, Kubis SE, Tolomeo P, Bilker WB, Han JH, Lautenbach E, Coffin SE, Gerber JS. Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study. Journal of the Pediatric Infectious Diseases Society. PMID 30476186 DOI: 10.1093/jpids/piy113  0.407
2018 Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheeler MK, Tolomeo P, Han JH. Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae. Infection Control and Hospital Epidemiology. 1-5. PMID 30375298 DOI: 10.1017/Ice.2018.254  0.429
2018 Tamma PD, Pierce VM, Cosgrove SE, Lautenbach E, Harris A, Rayapati D, Han JH. Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes? Open Forum Infectious Diseases. 5: ofy139. PMID 29992175 DOI: 10.1093/Ofid/Ofy139  0.325
2018 Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH. Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis. Critical Care Medicine. 46: 1106-1113. PMID 29912095 DOI: 10.1097/Ccm.0000000000003137  0.302
2018 Miano TA, Lautenbach E, Wilson FP, Guo W, Borovskiy Y, Hennessy S. Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29545383 DOI: 10.2215/Cjn.06980717  0.319
2018 Clarke E, Reesey E, Lautenbach E, Wernovsky M, Kelly BJ, Program CPE. 614. Modeling Changes in Gastrointestinal and Respiratory Tract Bacterial Community Diversity Attributable to Common Antibiotic Exposures During Long-Term Acute Care Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.621  0.31
2018 Lautenbach E, Pegues D, Fuchs B, Martin N, Nachamkin I, Bilker W, Tolomeo P, Cressman L, Omorgobe J, Johnson K, Han J, Program CPE. 1961. A Randomized Controlled Trial of the Effect of Accelerated Copper Textiles on Healthcare-Associated Infections and Multidrug-Resistant Organisms: The “Investigating Microbial Pathogen Activity of Copper Textiles” (IMPACT) Study Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.1617  0.389
2018 Hamilton KW, Cluzet V, Cressman L, Bilker W, Lautenbach E, Program CPE. 1800. Clinical Impact of Real-Time Predictive Model to Facilitate Antibiotic Prescribing in Gram-Negative Bacteremia Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.1456  0.321
2018 Anesi J, Lautenbach E, Nachamkin I, Garrigan C, Bilker W, Omorogbe J, Dankwa L, Wheeler MK, Tolomeo P, Han J, Epicenters CP. 1168. Role of Extended-Spectrum Cephalosporin-Resistance in Recurrent Enterobacteriaceae Urinary Tract Infections Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.1001  0.437
2017 Chotiprasitsakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Conley AT, Tolomeo P, Wise J, Tamma PD. Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29190320 DOI: 10.1093/Cid/Cix767  0.352
2017 Shahbazian JH, Hahn PD, Ludwig S, Ferguson J, Baron P, Christ A, Spicer K, Tolomeo P, Torrie AM, Bilker WB, Cluzet VC, Hu B, Julian K, Nachamkin I, Rankin SC, ... ... Lautenbach E, et al. Multidrug and mupirocin resistance in environmental methicillin-resistant Staphylococcus aureus (MRSA) collected from the homes of people diagnosed with a community-onset (CO-) MRSA infection. Applied and Environmental Microbiology. PMID 28939607 DOI: 10.1128/Aem.01369-17  0.485
2017 Lautenbach E. Infectious Diseases Careers in Healthcare Epidemiology and Antimicrobial Stewardship. The Journal of Infectious Diseases. 216: S620-S621. PMID 28938042 DOI: 10.1093/Infdis/Jix271  0.316
2017 Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E. High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli. Annals of Clinical Microbiology and Antimicrobials. 16: 25. PMID 28390438 DOI: 10.1186/S12941-017-0202-4  0.699
2017 Tsalik EL, Petzold E, Kreiswirth BN, Bonomo RA, Banerjee R, Lautenbach E, Evans SR, Hanson KE, Klausner JD, Patel R. Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 64: S41-S47. PMID 28350903 DOI: 10.1093/Cid/Ciw831  0.364
2017 Anderson DJ, Jenkins TC, Evans SR, Harris AD, Weinstein RA, Tamma PD, Han JH, Banerjee R, Patel R, Zaoutis T, Lautenbach E. The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 64: S36-S40. PMID 28350902 DOI: 10.1093/Cid/Ciw830  0.446
2017 Anesi J, Lautenbach E, Nachamkin I, Garrigan C, Bilker W, Dankwa L, Wheeler MK, Tolomeo P, Han J. Poor Clinical Outcomes Associated with Community-Onset Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae Urinary Tract Infections Open Forum Infectious Diseases. 4: S347-S347. DOI: 10.1093/Ofid/Ofx163.832  0.413
2017 Varga A, Cressman L, Lautenbach E, Cluzet V, Tolomeo P, Bilker W, Hamilton K. Use of a Precision Antibiotic Therapy (PAT) Prediction Model to Identify Multidrug-Resistant (MDR) Enterobacteriaceae Open Forum Infectious Diseases. 4: S328-S328. DOI: 10.1093/Ofid/Ofx163.775  0.388
2017 Davis M, Morris D, Cluzet V, Bilker W, Tolomeo P, Julian KG, Baron P, Brazil A, Ferguson J, Iverson SA, Shahbazian J, Ludwig S, Hu B, Rankin S, Nachamkin I, ... Lautenbach E, et al. Home environmental contamination is associated with community-associated methicillin-resistant Staphylococcus aureus re-colonization in treated patients Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx162.016  0.407
2016 Han JH, Goldstein EJ, Wise J, Bilker WB, Tolomeo P, Lautenbach E. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28013258 DOI: 10.1093/Cid/Ciw856  0.357
2016 Han JH, Garrigan C, Johnston B, Nachamkin I, Clabots C, Bilker WB, Santana E, Tolomeo P, Maslow J, Myers J, Carson L, Lautenbach E, Johnson JR. Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli. Diagnostic Microbiology and Infectious Disease. PMID 27939288 DOI: 10.1016/J.Diagmicrobio.2016.11.016  0.396
2016 Bushen JL, Mehta JM, Hamilton KW, Shawn Binkley, Timko DR, Lautenbach E, Pegues DA. Impact of Two Different Antimicrobial Stewardship Methods on Frequency of Streamlining Antimicrobial Agents in Patients with Bacteremia. Infection Control and Hospital Epidemiology. 1-7. PMID 27825392 DOI: 10.1017/Ice.2016.243  0.394
2016 Kerlin MP, Trick WE, Anderson DJ, Babcock HM, Lautenbach E, Gueret R, Klompas M. Interrater Reliability of Surveillance for Ventilator-Associated Events and Pneumonia. Infection Control and Hospital Epidemiology. 1-7. PMID 27821207 DOI: 10.1017/Ice.2016.262  0.346
2016 Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Wheeler M, Tolomeo P, Han JH. Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae. Infection Control and Hospital Epidemiology. 1-7. PMID 27678022 DOI: 10.1017/Ice.2016.225  0.406
2016 Cluzet VC, Gerber JS, Metlay JP, Nachamkin I, Zaoutis TE, Davis MF, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker WB, Han X, Mistry RD, Gavin LJ, ... ... Lautenbach E, et al. The Effect of Total Household Decolonization on Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology. 1-8. PMID 27465112 DOI: 10.1017/Ice.2016.138  0.402
2016 Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Masey C, Tamma PD. A Clinical Decision Tree to Predict Whether a Bacteremic Patient is Infected With an ESBL-Producing Organism. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27358356 DOI: 10.1093/Cid/Ciw425  0.349
2016 Downes KJ, Weiss SL, Gerber JS, Klieger SB, Fitzgerald JC, Balamuth F, Kubis SE, Tolomeo P, Bilker WB, Han X, Nachamkin I, Garrigan C, Han JH, Lautenbach E, Coffin SE, et al. A Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) Study. Journal of the Pediatric Infectious Diseases Society. PMID 27147715 DOI: 10.1093/Jpids/Piw023  0.398
2016 Davis MF, Hu B, Carroll K, Bilker WB, Tolomeo P, Cluzet VC, Baron P, Ferguson JM, Morris DO, Rankin SC, Lautenbach E, Nachamkin I. Comparison of culture-based methods to identify colonization with methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the context of co-colonization. Journal of Clinical Microbiology. PMID 27122377 DOI: 10.1128/Jcm.00132-16  0.36
2016 Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH. Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis. Diagnostic Microbiology and Infectious Disease. PMID 26971636 DOI: 10.1016/J.Diagmicrobio.2016.01.003  0.368
2016 Cluzet VC, Lautenbach E. Editorial Commentary: We Are Seeing More Sepsis  …. But Are We Seeing the Whole Picture? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: 704-6. PMID 26787174 DOI: 10.1093/Cid/Civ1023  0.313
2015 Davis MF, Misic AM, Morris DO, Moss JT, Tolomeo P, Beiting DP, Nachamkin I, Lautenbach E, Rankin SC. Genome sequencing reveals strain dynamics of methicillin-resistant Staphylococcus aureus in the same household in the context of clinical disease in a person and a dog. Veterinary Microbiology. PMID 26411322 DOI: 10.1016/J.Vetmic.2015.09.007  0.396
2015 Han JH, Nachamkin I, Coffin SE, Gerber JS, Fuchs B, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Lautenbach E. Use of a combination biomarker algorithm to identify medical intensive care unit patients with suspected sepsis at very low likelihood of bacterial infection. Antimicrobial Agents and Chemotherapy. PMID 26239984 DOI: 10.1128/Aac.00958-15  0.37
2015 Evans SR, Rubin D, Follmann D, Pennello G, Huskins WC, Powers JH, Schoenfeld D, Chuang-Stein C, Cosgrove SE, Fowler VG, Lautenbach E, Chambers HF. Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: 800-6. PMID 26113652 DOI: 10.1093/Cid/Civ495  0.366
2015 Morgan DJ, Braun B, Milstone AM, Anderson D, Lautenbach E, Safdar N, Drees M, Meddings J, Linkin DR, Croft LD, Pineles L, Diekema DJ, Harris AD. Lessons learned from hospital Ebola preparation. Infection Control and Hospital Epidemiology. 36: 627-31. PMID 25994323 DOI: 10.1017/Ice.2015.61  0.36
2015 Manning S, Lautenbach E, Tolomeo P, Han JH. Risk factors for infection with Escherichia coli in nursing home residents colonized with fluoroquinolone-resistant E. coli. Infection Control and Hospital Epidemiology. 36: 575-7. PMID 25880678 DOI: 10.1017/Ice.2015.3  0.41
2015 Cluzet VC, Gerber JS, Nachamkin I, Metlay JP, Zaoutis TE, Davis MF, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker WB, Han X, Mistry RD, Gavin LJ, ... ... Lautenbach E, et al. Risk Factors for Recurrent Colonization With Methicillin-Resistant Staphylococcus aureus in Community-Dwelling Adults and Children. Infection Control and Hospital Epidemiology. 36: 786-93. PMID 25869756 DOI: 10.1017/Ice.2015.76  0.443
2015 Cluzet VC, Lautenbach E, Nachamkin I, Cary MS, Fishman NO, Shih NN, Morales KH, Linkin DR. Risk factors for gyrA and parC mutations in Pseudomonas aeruginosa. Infection Control and Hospital Epidemiology. 36: 387-93. PMID 25782892 DOI: 10.1017/Ice.2014.87  0.33
2015 Milder EA, Rizzi MD, Morales KH, Ross RK, Lautenbach E, Gerber JS. Impact of a new practice guideline on antibiotic use with pediatric tonsillectomy. Jama Otolaryngology-- Head & Neck Surgery. 141: 410-6. PMID 25719954 DOI: 10.1001/Jamaoto.2015.95  0.328
2015 Misic AM, Davis MF, Tyldsley AS, Hodkinson BP, Tolomeo P, Hu B, Nachamkin I, Lautenbach E, Morris DO, Grice EA. The shared microbiota of humans and companion animals as evaluated from Staphylococcus carriage sites. Microbiome. 3: 2. PMID 25705378 DOI: 10.1186/S40168-014-0052-7  0.351
2015 Cluzet VC, Gerber JS, Nachamkin I, Metlay JP, Zaoutis TE, Davis MF, Julian KG, Royer D, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Mistry RD, Gavin LJ, Tolomeo P, ... ... Lautenbach E, et al. Duration of Colonization and Determinants of Earlier Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1489-96. PMID 25648237 DOI: 10.1093/Cid/Civ075  0.458
2015 Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E. Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study. The Journal of Antimicrobial Chemotherapy. 70: 1547-51. PMID 25630645 DOI: 10.1093/Jac/Dku548  0.718
2015 Iverson SA, Brazil AM, Ferguson JM, Nelson K, Lautenbach E, Rankin SC, Morris DO, Davis MF. Anatomical patterns of colonization of pets with staphylococcal species in homes of people with methicillin-resistant Staphylococcus aureus (MRSA) skin or soft tissue infection (SSTI). Veterinary Microbiology. 176: 202-8. PMID 25623014 DOI: 10.1016/J.Vetmic.2015.01.003  0.371
2015 Hamilton KW, Gerber JS, Moehring R, Anderson DJ, Calderwood MS, Han JH, Mehta JM, Pollack LA, Zaoutis T, Srinivasan A, Camins BC, Schwartz DN, Lautenbach E. Point-of-prescription interventions to improve antimicrobial stewardship. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1252-8. PMID 25595748 DOI: 10.1093/Cid/Civ018  0.403
2015 Han J, Nachamkin I, Garrigan C, Bilker W, Wheeler MK, Tolomeo P, Lautenbach E. Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1353  0.325
2015 Han J, Nachamkin I, Coffin S, Gerber JS, Garrigan C, Han X, Bilker W, Wise J, Tolomeo P, Lautenbach E. Use of a Combination Biomarker Algorithm to Identify Critically Ill Surgical Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1058  0.359
2015 Han J, Nachamkin I, Coffin S, Gerber JS, Fuchs B, Garrigan C, Han X, Bilker W, Wise J, Tolomeo P, Lautenbach E. Use of a Combination Biomarker Algorithm to Identify Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1057  0.347
2015 Downes K, Weiss S, Klieger SB, Fitzgerald J, Balamuth F, Kubis S, Tolomeo P, Bilker W, Han X, Nachamkin I, Garrigan C, Han J, Lautenbach E, Gerber JS, Coffin S. Developing a Biomarker-Driven Algorithm to Improve Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) Study Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv131.117  0.332
2015 Davis M, Morris D, Bilker W, Tolomeo P, Julian K, Baron P, Brazil A, Ferguson J, Iverson S, Hu B, Rankin S, Nachamkin I, Lautenbach E. Companion animals and home surface contamination in community-associated methicillin-resistant Staphylococcus aureus colonization of people Annals of Global Health. 81: 126. DOI: 10.1016/J.Aogh.2015.02.790  0.331
2014 Han JH, Johnston B, Nachamkin I, Tolomeo P, Bilker WB, Mao X, Clabots C, Lautenbach E, Johnson JR. Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli. Antimicrobial Agents and Chemotherapy. 58: 7003-6. PMID 25199782 DOI: 10.1128/Aac.03256-14  0.39
2014 Mehta JM, Haynes K, Wileyto EP, Gerber JS, Timko DR, Morgan SC, Binkley S, Fishman NO, Lautenbach E, Zaoutis T. Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infection Control and Hospital Epidemiology. 35: 1092-9. PMID 25111916 DOI: 10.1086/677624  0.302
2014 Chambers HF, Bartlett JG, Bonomo RA, Chiou C, Cosgrove SE, Cross HR, Daum RS, Downing M, Evans SR, Knisely J, Kreiswirth BN, Lautenbach E, Mickley BS, Patel R, Pettigrew MM, et al. Antibacterial resistance leadership group: open for business. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1571-6. PMID 24610430 DOI: 10.1093/Cid/Ciu132  0.414
2014 Lautenbach E, Perencevich EN. Addressing the emergence and impact of multidrug-resistant gram-negative organisms: a critical focus for the next decade. Infection Control and Hospital Epidemiology. 35: 333-5. PMID 24602935 DOI: 10.1086/675592  0.379
2014 Han JH, Maslow J, Han X, Xie SX, Tolomeo P, Santana E, Carson L, Lautenbach E. Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities. The Journal of Infectious Diseases. 209: 420-5. PMID 23986544 DOI: 10.1093/Infdis/Jit471  0.386
2014 Manning S, Lautenbach E, Tolomeo P, Han J. 344Risk Factors for Infection with Escherichia coli among Long-Term Care Facility Residents with Gastrointestinal Tract Colonization with Fluoroquinolone-Resistant E. coli Open Forum Infectious Diseases. 1: S137-S137. DOI: 10.1093/Ofid/Ofu052.210  0.425
2014 Cluzet VC, Gerber JS, Nachamkin I, Metlay J, Zaoutis T, Julian KG, Royer D, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Mistry RD, Gavin LJ, Tolomeo P, Wise J, ... ... Lautenbach E, et al. 299Duration of Colonization with Methicillin-resistant Staphylococcus aureus and Determinants of More Rapid Clearance of Colonization Open Forum Infectious Diseases. 1: S124-S125. DOI: 10.1093/Ofid/Ofu052.165  0.437
2014 Cluzet VC, Tolomeo P, Lautenbach E. 279Prevalence and Epidemiology of Mupirocin Resistance Among Those Colonized with Methicillin-resistant Staphylococcus aureus in the Community Open Forum Infectious Diseases. 1: S117-S117. DOI: 10.1093/Ofid/Ofu052.145  0.421
2014 Cluzet VC, Gerber JS, Metlay J, Nachamkin I, Zaoutis T, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker W, Han X, Mistry RD, Gavin LJ, Tolomeo P, ... ... Lautenbach E, et al. 1336A Randomized Controlled Trial of the Effect of Total Household Decolonization on Termination of Colonization with Methicillin-Resistant Staphylococcus aureus Open Forum Infectious Diseases. 1: S57-S57. DOI: 10.1093/Ofid/Ofu051.153  0.354
2014 Milder E, Rizzi M, Morales K, Ross R, Lautenbach E, Gerber JS. 1325Impact of a New Practice Guideline on Antibiotic Use with Pediatric Tonsillectomy Open Forum Infectious Diseases. 1. DOI: 10.1093/Ofid/Ofu051.142  0.317
2013 Han JH, Bilker WB, Nachamkin I, Zaoutis TE, Coffin SE, Linkin DR, Hu B, Tolomeo P, Fishman NO, Lautenbach E. The effect of a hospital-wide urine culture screening intervention on the incidence of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species. Infection Control and Hospital Epidemiology. 34: 1160-6. PMID 24113599 DOI: 10.1086/673453  0.317
2013 Han JH, Bilker WB, Nachamkin I, Tolomeo P, Mao X, Fishman NO, Lautenbach E. Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility. Infection Control and Hospital Epidemiology. 34: 1070-6. PMID 24018924 DOI: 10.1086/673155  0.477
2013 Lautenbach E. Editorial commentary: flying under the radar: the stealth pandemic of Escherichia coli sequence type 131. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1266-9. PMID 23926177 DOI: 10.1093/Cid/Cit505  0.391
2013 Linkin DR, Fishman NO, Shea JA, Yang W, Cary MS, Lautenbach E. Public reporting of hospital-acquired infections is not associated with improved processes or outcomes. Infection Control and Hospital Epidemiology. 34: 844-6. PMID 23838228 DOI: 10.1086/671279  0.359
2013 Keller SC, Linkin DR, Fishman NO, Lautenbach E. Variations in identification of healthcare-associated infections. Infection Control and Hospital Epidemiology. 34: 678-86. PMID 23739071 DOI: 10.1086/670999  0.35
2013 Han JH, Nachamkin I, Tolomeo P, Mao X, Bilker WB, Lautenbach E. Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones. Diagnostic Microbiology and Infectious Disease. 76: 491-6. PMID 23719087 DOI: 10.1016/J.Diagmicrobio.2013.04.018  0.423
2013 Codrington L, Kuncio D, Han J, Nachamkin I, Tolomeo P, Hu B, Lautenbach E. Yield of methicillin-resistant Staphylococcus aureus on moist swabs versus dry swabs. American Journal of Infection Control. 41: 469-70. PMID 23337302 DOI: 10.1016/J.Ajic.2012.09.011  0.42
2013 Greenblatt RM, Han JH, Nachamkin I, Tolomeo P, Lautenbach E. Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions. Infection Control and Hospital Epidemiology. 34: 40-8. PMID 23221191 DOI: 10.1086/668780  0.386
2013 Feemster KA, Li Y, Localio AR, Shults J, Edelstein P, Lautenbach E, Smith T, Metlay JP. Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies. Epidemiology and Infection. 141: 1679-89. PMID 23114061 DOI: 10.1017/S095026881200235X  0.3
2013 Han JH, Edelstein PH, Bilker WB, Lautenbach E. The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia. The Journal of Infection. 66: 41-7. PMID 22960078 DOI: 10.1016/J.Jinf.2012.09.001  0.421
2013 Han JH, Bilker WB, Edelstein PH, Mascitti KB, Lautenbach E. Derivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemia Epidemiology and Infection. 141: 165-173. PMID 22490228 DOI: 10.1017/S0950268812000295  0.333
2012 Han JH, Nachamkin I, Zaoutis TE, Coffin SE, Linkin DR, Fishman NO, Weiner MG, Hu B, Tolomeo P, Lautenbach E. Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients. Infection Control and Hospital Epidemiology. 33: 1242-5. PMID 23143363 DOI: 10.1086/668443  0.38
2012 Han JH, Nachamkin I, Tolomeo P, Mao X, Bilker WB, Lautenbach E. Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli. The Journal of Infectious Diseases. 206: 1597-603. PMID 22966123 DOI: 10.1093/Infdis/Jis567  0.437
2012 Stone ND, Ashraf MS, Calder J, Crnich CJ, Crossley K, Drinka PJ, Gould CV, Juthani-Mehta M, Lautenbach E, Loeb M, Maccannell T, Malani PN, Mody L, Mylotte JM, Nicolle LE, et al. Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria. Infection Control and Hospital Epidemiology. 33: 965-77. PMID 22961014 DOI: 10.1086/667743  0.354
2012 Davis MF, Iverson SA, Baron P, Vasse A, Silbergeld EK, Lautenbach E, Morris DO. Household transmission of meticillin-resistant Staphylococcus aureus and other staphylococci. The Lancet. Infectious Diseases. 12: 703-16. PMID 22917102 DOI: 10.1016/S1473-3099(12)70156-1  0.398
2012 Han JH, Kasahara K, Edelstein PH, Bilker WB, Lautenbach E. Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli. Antimicrobial Agents and Chemotherapy. 56: 5575-80. PMID 22890772 DOI: 10.1128/Aac.01136-12  0.4
2012 Han JH, Mascitti KB, Edelstein PH, Bilker WB, Lautenbach E. Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia. Antimicrobial Agents and Chemotherapy. 56: 5164-70. PMID 22825122 DOI: 10.1128/Aac.00757-12  0.407
2012 Han JH, Edelstein PH, Lautenbach E. Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia. The Journal of Antimicrobial Chemotherapy. 67: 2346-9. PMID 22761330 DOI: 10.1093/Jac/Dks255  0.414
2012 Morgan DJ, Meddings J, Saint S, Lautenbach E, Shardell M, Anderson D, Milstone AM, Drees M, Pineles L, Safdar N, Bowling J, Henderson D, Yokoe D, Harris AD. Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 923-9. PMID 22700826 DOI: 10.1093/Cid/Cis556  0.373
2012 Lautenbach E, Han J, Santana E, Tolomeo P, Bilker WB, Maslow J. Colonization with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in long-term care facility residents. Infection Control and Hospital Epidemiology. 33: 302-4. PMID 22314070 DOI: 10.1086/664055  0.327
2012 Morris DO, Lautenbach E, Zaoutis T, Leckerman K, Edelstein PH, Rankin SC. Potential for Pet Animals to Harbour Methicillin-Resistant Staphylococcus aureus When Residing with Human MRSA Patients Zoonoses and Public Health. 59: 286-293. PMID 22233337 DOI: 10.1111/J.1863-2378.2011.01448.X  0.383
2012 Mascitti KB, Edelstein PH, Fishman NO, Morales KH, Baltus AJ, Lautenbach E. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia. Infection Control and Hospital Epidemiology. 33: 160-6. PMID 22227985 DOI: 10.1086/663708  0.469
2012 Liu Z, Nachamkin I, Edelstein PH, Lautenbach E, Metlay JP. Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era. Antimicrobial Agents and Chemotherapy. 56: 743-50. PMID 22123697 DOI: 10.1128/Aac.05122-11  0.309
2012 Linkin DR, Lautenbach E. Studying Effects of Antibiotics Pharmacoepidemiology, Fifth Edition. 827-839. DOI: 10.1002/9781119959946.ch44  0.342
2011 Rattanaumpawan P, Tolomeo P, Bilker WB, Lautenbach E. A clinical prediction rule for fluoroquinolone resistance in healthcare-acquired gram-negative urinary tract infection. Infection Control and Hospital Epidemiology. 32: 1124-6. PMID 22011542 DOI: 10.1086/662379  0.696
2011 Lemonovich TL, Haynes K, Lautenbach E, Amorosa VK. Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: A cohort study Infection. 39: 549-554. PMID 21898120 DOI: 10.1007/S15010-011-0189-2  0.358
2011 Rattanaumpawan P, Morales KH, Binkley S, Synnestvedt M, Weiner MG, Gasink LB, Fishman NO, Lautenbach E. Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy. The Journal of Antimicrobial Chemotherapy. 66: 2655-8. PMID 21803769 DOI: 10.1093/Jac/Dkr321  0.678
2011 Akhabue E, Synnestvedt M, Weiner MG, Bilker WB, Lautenbach E. Cefepime-resistant Pseudomonas aeruginosa. Emerging Infectious Diseases. 17: 1037-43. PMID 21749765 DOI: 10.3201/Eid/1706.100358  0.453
2011 Perencevich EN, Lautenbach E. Infection prevention and comparative effectiveness research. Jama. 305: 1482-3. PMID 21486981 DOI: 10.1001/Jama.2011.450  0.37
2011 Fanelli M, Kupperman E, Lautenbach E, Edelstein PH, Margolis DJ. Antibiotics, acne, and Staphylococcus aureus colonization. Archives of Dermatology. 147: 917-21. PMID 21482860 DOI: 10.1001/Archdermatol.2011.67  0.425
2011 Woeltje KF, Lautenbach E. Informatics and epidemiology in infection control. Infectious Disease Clinics of North America. 25: 261-70. PMID 21316004 DOI: 10.1016/J.Idc.2010.11.013  0.318
2011 Bramble M, Morris D, Tolomeo P, Lautenbach E. Potential role of pet animals in household transmission of methicillin-resistant Staphylococcus aureus: a narrative review. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.). 11: 617-20. PMID 21142959 DOI: 10.1089/Vbz.2010.0025  0.387
2011 Rattanaumpawan P, Tolomeo P, Bilker WB, Fishman NO, Lautenbach E. Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients. Epidemiology and Infection. 139: 955-61. PMID 20696087 DOI: 10.1017/S095026881000186X  0.721
2010 Lautenbach E, Lee I, Shiley KT. Treating viral respiratory tract infections with antibiotics in hospitals: no longer a case of mistaken identity. Ldi Issue Brief. 16: 1-4. PMID 21280386  0.39
2010 Marin JR, Bilker W, Lautenbach E, Alpern ER. Reliability of clinical examinations for pediatric skin and soft-tissue infections. Pediatrics. 126: 925-30. PMID 20974788 DOI: 10.1542/Peds.2010-1039  0.304
2010 Shiley KT, Lautenbach E, Lee I. The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics? Infection Control and Hospital Epidemiology. 31: 1177-83. PMID 20923284 DOI: 10.1086/656596  0.436
2010 Rattanaumpawan P, Tolomeo P, Bilker WB, Fishman NO, Lautenbach E. Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections. The Journal of Hospital Infection. 76: 324-7. PMID 20643497 DOI: 10.1016/J.Jhin.2010.05.023  0.717
2010 Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I. The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 51: 280-5. PMID 20597679 DOI: 10.1086/653931  0.438
2010 Lee I, Morales KH, Zaoutis TE, Fishman NO, Nachamkin I, Lautenbach E. Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections. American Journal of Infection Control. 38: 740-5. PMID 20542354 DOI: 10.1016/J.Ajic.2010.02.016  0.368
2010 M'ikanatha NM, Sandt CH, Localio AR, Tewari D, Rankin SC, Whichard JM, Altekruse SF, Lautenbach E, Folster JP, Russo A, Chiller TM, Reynolds SM, McDermott PF. Multidrug-resistant Salmonella isolates from retail chicken meat compared with human clinical isolates. Foodborne Pathogens and Disease. 7: 929-34. PMID 20443729 DOI: 10.1089/Fpd.2009.0499  0.388
2010 Mascitti KB, Gerber JS, Zaoutis TE, Barton TD, Lautenbach E. Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers. American Journal of Infection Control. 38: 324-8. PMID 20420965 DOI: 10.1016/J.Ajic.2009.11.007  0.404
2010 Lee I, Zaoutis TE, Fishman NO, Morales KH, Nachamkin I, Lautenbach E. Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: potential impact of control group selection on characterizing the association between previous fluconazole use and fluconazole resistance. American Journal of Infection Control. 38: 456-60. PMID 20371135 DOI: 10.1016/J.Ajic.2009.12.011  0.482
2010 M'ikanatha NM, Gasink LB, Kunselman A, Warren K, Lautenbach E. Child care center exclusion policies and directors' opinions on the use of antibiotics. Infection Control and Hospital Epidemiology. 31: 408-11. PMID 20175686 DOI: 10.1086/651305  0.302
2010 Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, Kim M. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infection Control and Hospital Epidemiology. 31: 47-53. PMID 19951202 DOI: 10.1086/649021  0.439
2010 Lautenbach E, Tolomeo P, Nachamkin I, Hu B, Zaoutis TE. The impact of household transmission on duration of outpatient colonization with methicillin-resistant Staphylococcus aureus Epidemiology and Infection. 138: 683-685. DOI: 10.1017/S0950268810000099  0.38
2009 Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infection Control and Hospital Epidemiology. 30: 1180-5. PMID 19860564 DOI: 10.1086/648451  0.361
2009 Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, Kim M. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infection Control and Hospital Epidemiology. 30: 1186-92. PMID 19860563 DOI: 10.1086/648450  0.488
2009 Lautenbach E. Antimicrobial resistance in gram-negative pathogens: crafting the tools necessary to navigate the long ascent out of the abyss. The Journal of Infectious Diseases. 200: 838-40. PMID 19673645 DOI: 10.1086/605409  0.423
2009 M'ikanatha NM, Churchill RE, Lautenbach E, Mactavish LE, Pollock TR, Weand CL, Polachek C, Reynolds SM, Ostroff SM. Training programs to strengthen Pennsylvania's public health response. Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science. 7: 178-86. PMID 19635002 DOI: 10.1089/Bsp.2009.0005  0.311
2009 Lautenbach E, Marsicano R, Tolomeo P, Heard M, Serrano S, Stieritz DD. Epidemiology of antimicrobial resistance among gram-negative organisms recovered from patients in a multistate network of long-term care facilities. Infection Control and Hospital Epidemiology. 30: 790-3. PMID 19566445 DOI: 10.1086/599070  0.409
2009 Cerceo E, Lautenbach E, Linkin DR, Bilker WB, Lee I. Role of matching in case-control studies of antimicrobial resistance. Infection Control and Hospital Epidemiology. 30: 479-83. PMID 19335226 DOI: 10.1086/597061  0.334
2009 Lautenbach E, Babson A, Santana E, Tolomeo P, Black N, Smith CA, Maslow J. Assessment of the use of urine samples to detect colonization with fluoroquinolone-susceptible and fluoroquinolone-resistant Escherichia coli. Infection Control and Hospital Epidemiology. 30: 396-7. PMID 19245313 DOI: 10.1086/596044  0.403
2009 Lautenbach E, Nachamkin I, Hu B, Fishman NO, Tolomeo P, Prasad P, Bilker WB, Zaoutis TE. Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infection Control and Hospital Epidemiology. 30: 380-2. PMID 19239378 DOI: 10.1086/596045  0.389
2009 Lee I, Fishman NO, Zaoutis TE, Morales KH, Weiner MG, Synnestvedt M, Nachamkin I, Lautenbach E. Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Archives of Internal Medicine. 169: 379-83. PMID 19237722 DOI: 10.1001/Archinte.169.4.379  0.473
2009 Kanafani ZA, Arduino JM, Muhlbaier LH, Kaye KS, Allen KB, Carmeli Y, Corey GR, Cosgrove SE, Fraser TG, Harris AD, Karchmer AW, Lautenbach E, Rupp ME, Peterson ED, Straus WL, et al. Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery. Infection Control and Hospital Epidemiology. 30: 242-8. PMID 19199534 DOI: 10.1086/596015  0.383
2009 Lautenbach E, Metlay JP, Weiner MG, Bilker WB, Tolomeo P, Mao X, Nachamkin I, Fishman NO. Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infection Control and Hospital Epidemiology. 30: 18-24. PMID 19046057 DOI: 10.1086/592703  0.445
2008 Lautenbach E. Finding the path of least antimicrobial resistance in pyelonephritis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 1159-61. PMID 18808350 DOI: 10.1086/592251  0.378
2008 Cohen KA, Lautenbach E, Weiner MG, Synnestvedt M, Gasink LB. Coadministration of oral levofloxacin with agents that impair absorption: impact on antibiotic resistance. Infection Control and Hospital Epidemiology. 29: 975-7. PMID 18808343 DOI: 10.1086/590666  0.377
2008 Cohen AL, Calfee D, Fridkin SK, Huang SS, Jernigan JA, Lautenbach E, Oriola S, Ramsey KM, Salgado CD, Weinstein RA. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper . Infection Control and Hospital Epidemiology. 29: 901-13. PMID 18808340 DOI: 10.1086/591741  0.418
2008 Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, Mody L, Nicolle L, Stevenson K. SHEA/APIC Guideline: Infection prevention and control in the long-term care facility. American Journal of Infection Control. 36: 504-35. PMID 18786461 DOI: 10.1016/J.Ajic.2008.06.001  0.366
2008 Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, Mody L, Nicolle L, Stevenson K. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infection Control and Hospital Epidemiology. 29: 785-814. PMID 18767983 DOI: 10.1086/592416  0.383
2008 Lautenbach E. Expanding the universe of methicillin-resistant Staphylococcus aureus prevention. Annals of Internal Medicine. 148: 474-6. PMID 18347352 DOI: 10.7326/0003-4819-148-6-200803180-00009  0.383
2008 Gasink LB, Lautenbach E. Prevention and treatment of health care-acquired infections. The Medical Clinics of North America. 92: 295-313, viii. PMID 18298980 DOI: 10.1016/J.Mcna.2007.10.002  0.387
2008 Lautenbach E, Santana E, Lee A, Tolomeo P, Black N, Babson A, Perencevich EN, Harris AD, Smith CA, Maslow J. Efficient recovery of fluoroquinolone-susceptible and fluoroquinolone-resistant Escherichia coli strains from frozen samples. Infection Control and Hospital Epidemiology. 29: 367-9. PMID 18279070 DOI: 10.1086/529590  0.306
2008 Kim JY, Lautenbach E, Chu J, Goyal M, Nachamkin I, McGowan K, Coffin S, Zaoutis T. Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species. American Journal of Infection Control. 36: 70-3. PMID 18241740 DOI: 10.1016/J.Ajic.2007.01.012  0.464
2008 Meropol SB, Chan KA, Chen Z, Finkelstein JA, Hennessy S, Lautenbach E, Platt R, Schech SD, Shatin D, Metlay JP. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiology and Drug Safety. 17: 523-32. PMID 18215001 DOI: 10.1002/Pds.1547  0.315
2008 Gasink LB, Singer K, Fishman NO, Holmes WC, Weiner MG, Bilker WB, Lautenbach E. Contact isolation for infection control in hospitalized patients: is patient satisfaction affected? Infection Control and Hospital Epidemiology. 29: 275-8. PMID 18205528 DOI: 10.1086/527508  0.333
2008 Anthony KB, Fishman NO, Linkin DR, Gasink LB, Edelstein PH, Lautenbach E. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 567-70. PMID 18199038 DOI: 10.1086/526775  0.463
2008 Tolomeo P, Wheeler M, Metlay JP, Armstrong K, Fishman NO, Bilker WB, Lautenbach E. Patient attitudes regarding participation in studies of antimicrobial resistance. Infection Control and Hospital Epidemiology. 29: 155-9. PMID 18179371 DOI: 10.1086/526447  0.407
2007 Gasink LB, Zaoutis TE, Bilker WB, Lautenbach E. The categorization of prior antibiotic use: impact on the identification of risk factors for drug resistance in case control studies. American Journal of Infection Control. 35: 638-42. PMID 18063127 DOI: 10.1016/J.Ajic.2007.01.011  0.44
2007 Lautenbach E, Polk RE. Resistant gram-negative bacilli: A neglected healthcare crisis? American Journal of Health-System Pharmacy. 64. PMID 18029939 DOI: 10.2146/Ajhp070477  0.476
2007 Buckley J, Coffin SE, Lautenbach E, Prasad P, Chu J, Goyal M, Zaoutis TE. Outcome of Escherichia coli and/or Klebsiella bloodstream infection in children with central venous catheters Infection Control and Hospital Epidemiology. 28: 1308-1310. PMID 17926284 DOI: 10.1086/521659  0.366
2007 Hyle EP, Gasink LB, Linkin DR, Bilker WB, Lautenbach E. Use of different thresholds of prior antimicrobial use in defining exposure: Impact on the association between antimicrobial use and antimicrobial resistance Journal of Infection. 55: 414-418. PMID 17850877 DOI: 10.1016/J.Jinf.2007.07.005  0.377
2007 Gasink LB, Fishman NO, Nachamkin I, Bilker WB, Lautenbach E. Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa Infection Control and Hospital Epidemiology. 28: 1175-1180. PMID 17828695 DOI: 10.1086/520740  0.495
2007 Hennessy S, Bilker WB, Leonard CE, Chittams J, Palumbo CM, Karlawish JH, Yang YX, Lautenbach E, Baine WB, Metlay JP. Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. Journal of Clinical Epidemiology. 60: 911-8. PMID 17689807 DOI: 10.1016/J.Jclinepi.2006.11.022  0.335
2007 Hamilton KW, Bilker WB, Lautenbach E. Controlling for severity of illness in assessment of the association between antimicrobial-resistant infection and mortality: impact of calculation of Acute Physiology and Chronic Health Evaluation (APACHE) II scores at different time points Infection Control and Hospital Epidemiology. 28: 832-836. PMID 17564986 DOI: 10.1086/518751  0.377
2007 Hyle EP, Bilker WB, Gasink LB, Lautenbach E. Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection Infection Control and Hospital Epidemiology. 28: 647-654. PMID 17520535 DOI: 10.1086/516798  0.437
2007 LaRosa LA, Fishman NO, Lautenbach E, Koppel RJ, Morales KH, Linkin DR. Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of "stealth dosing". Infection Control and Hospital Epidemiology. 28: 551-6. PMID 17464914 DOI: 10.1086/513535  0.362
2007 Kagen J, Bilker WB, Lautenbach E, Bell LM, Coffin SE, St John KH, Teszner E, Dominguez T, Gaynor JW, Shah SS. Risk adjustment for surgical site infection after median sternotomy in children. Infection Control and Hospital Epidemiology. 28: 398-405. PMID 17385144 DOI: 10.1086/513123  0.357
2007 Shah SS, Kagen J, Lautenbach E, Bilker WB, Matro J, Dominguez TE, Tabbutt S, Gaynor JW, Bell LM. Bloodstream infections after median sternotomy at a children's hospital. The Journal of Thoracic and Cardiovascular Surgery. 133: 435-40. PMID 17258580 DOI: 10.1016/J.Jtcvs.2006.09.026  0.383
2007 Han Z, Lautenbach E, Fishman N, Nachamkin I. Evaluation of mannitol salt agar, CHROMagar Staph aureus and CHROMagar MRSA for detection of meticillin-resistant Staphylococcus aureus from nasal swab specimens Journal of Medical Microbiology. 56: 43-46. PMID 17172515 DOI: 10.1099/Jmm.0.46777-0  0.403
2006 Gupta G, Lautenbach E, Lewis JD. Incidence and Risk Factors for Herpes Zoster Among Patients With Inflammatory Bowel Disease Clinical Gastroenterology and Hepatology. 4: 1483-1490. PMID 17162240 DOI: 10.1016/J.Cgh.2006.09.019  0.302
2006 Cohen AE, Lautenbach E, Morales KH, Linkin DR. Fluoroquinolone-resistant Escherichia coli in the long-term care setting. The American Journal of Medicine. 119: 958-63. PMID 17071164 DOI: 10.1016/J.Amjmed.2006.05.030  0.387
2006 Lautenbach E, Tolomeo P, Mao X, Fishman NO, Metlay JP, Bilker WB, Nachamkin I. Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital. Antimicrobial Agents and Chemotherapy. 50: 3939-43. PMID 16982789 DOI: 10.1128/Aac.00503-06  0.398
2006 Lautenbach E, Weiner MG, Nachamkin I, Bilker WB, Sheridan A, Fishman NO. Imipenem resistance among Pseudomonas aeruginosa isolates: Risk factors for infection and impact of resistance on clinical and economic outcomes Infection Control and Hospital Epidemiology. 27: 893-900. PMID 16941312 DOI: 10.1086/507274  0.486
2006 MacAdam H, Zaoutis TE, Gasink LB, Bilker WB, Lautenbach E. Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use International Journal of Antimicrobial Agents. 28: 325-332. PMID 16934439 DOI: 10.1016/J.Ijantimicag.2006.04.014  0.446
2006 Linkin DR, Paris S, Fishman NO, Metlay JP, Lautenbach E. Inaccurate communications in telephone calls to an antimicrobial stewardship program. Infection Control and Hospital Epidemiology. 27: 688-94. PMID 16807843 DOI: 10.1086/505918  0.361
2006 Binkley S, Fishman NO, LaRosa LA, Marr AM, Nachamkin I, Wordell D, Bilker WB, Lautenbach E. Comparison of unit-specific and hospital-wide antibiograms: Potential implications for selection of empirical antimicrobial therapy Infection Control and Hospital Epidemiology. 27: 682-687. PMID 16807842 DOI: 10.1086/505921  0.399
2006 Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, Samel C, Barbagallo S, Arentzen J, Lautenbach E. Reemergence of gram-negative health care-associated bloodstream infections. Archives of Internal Medicine. 166: 1289-94. PMID 16801511 DOI: 10.1001/Archinte.166.12.1289  0.366
2006 Gasink LB, Fishman NO, Weiner MG, Nachamkin I, Bilker WB, Lautenbach E. Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact American Journal of Medicine. 119. PMID 16750968 DOI: 10.1016/J.Amjmed.2005.11.029  0.472
2006 Lautenbach E, Fishman NO, Metlay JP, Mao X, Bilker WB, Tolomeo P, Nachamkin I. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. The Journal of Infectious Diseases. 194: 79-85. PMID 16741885 DOI: 10.1086/503046  0.374
2006 Mizuta M, Linkin DR, Nachamkin I, Fishman NO, Weiner MG, Sheridan A, Lautenbach E. Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram. Infection Control and Hospital Epidemiology. 27: 413-5. PMID 16622822 DOI: 10.1086/503175  0.345
2006 Lipworth AD, Hyle EP, Fishman NO, Nachamkin I, Bilker WB, Marr AM, Larosa LA, Kasbekar N, Lautenbach E. Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infection Control and Hospital Epidemiology. 27: 279-86. PMID 16532416 DOI: 10.1086/503016  0.307
2005 Quain RD, Barton TD, Fishman NO, Weiner MG, Lautenbach E. Coadministration of oral levofloxacin with agents that impair its absorption: Potential impact on emergence of resistance International Journal of Antimicrobial Agents. 26: 327-330. PMID 16154325 DOI: 10.1016/J.Ijantimicag.2005.04.021  0.387
2005 Shah SS, Lautenbach E, Long CB, Tabbutt S, Gaynor JW, Bilker WB, Bell LM. Staphylococcus aureus as a risk factor for bloodstream infection in children with postoperative mediastinitis. The Pediatric Infectious Disease Journal. 24: 834-7. PMID 16148854 DOI: 10.1097/01.Inf.0000176615.77854.7A  0.419
2005 Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 923-9. PMID 16142655 DOI: 10.1086/432940  0.352
2005 Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing enterobacteriaceae: Variability by site of infection Archives of Internal Medicine. 165: 1375-1380. PMID 15983286 DOI: 10.1001/Archinte.165.12.1375  0.479
2005 Maslow JN, Lee B, Lautenbach E. Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility. Emerging Infectious Diseases. 11: 889-94. PMID 15963284 DOI: 10.3201/Eid1106.041335  0.413
2005 Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance Clinical Infectious Diseases. 41: 77-82. PMID 15937766 DOI: 10.1086/430713  0.353
2005 Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species Clinical Infectious Diseases. 40: 1317-1324. PMID 15825035 DOI: 10.1086/429239  0.503
2005 Long CB, Shah SS, Lautenbach E, Coffin SE, Tabbutt S, Gaynor JW, Bell LM. Postoperative mediastinitis in children: epidemiology, microbiology and risk factors for Gram-negative pathogens. The Pediatric Infectious Disease Journal. 24: 315-9. PMID 15818290 DOI: 10.1097/01.Inf.0000157205.31624.Ed  0.321
2005 Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics. 115: 942-9. PMID 15805368 DOI: 10.1542/Peds.2004-1289  0.402
2005 Barton TD, Fishman NO, Weiner MG, LaRosa LA, Lautenbach E. High rate of coadministration of di- or tri-valent cation-containing compounds with oral fluoroquinolones: Risk factors and potential implications Infection Control and Hospital Epidemiology. 26: 93-99. PMID 15693415 DOI: 10.1086/502493  0.385
2005 Viray M, Linkin D, Maslow JN, Stieritz DD, Carson LS, Bilker WB, Lautenbach E. Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. Infection Control and Hospital Epidemiology. 26: 56-62. PMID 15693409 DOI: 10.1086/502487  0.444
2005 Lautenbach E, Harris AD, Perencevich EN, Nachamkin I, Tolomeo P, Metlay JP. Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract. Antimicrobial Agents and Chemotherapy. 49: 798-800. PMID 15673772 DOI: 10.1128/Aac.49.2.798-800.2005  0.336
2005 M'ikanatha NM, Julian KG, Kunselman AR, Aber RC, Rankin JT, Lautenbach E. Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak. Bmc Public Health. 5: 2. PMID 15634353 DOI: 10.1186/1471-2458-5-2  0.334
2005 Kersun LS, Propert KJ, Lautenbach E, Bunin N, Demichele A. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis. Pediatric Blood & Cancer. 45: 162-9. PMID 15593235 DOI: 10.1002/Pbc.20277  0.372
2004 Linkin DR, Fishman NO, Patel JB, Merrill JD, Lautenbach E. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit. Infection Control and Hospital Epidemiology. 25: 781-3. PMID 15484805 DOI: 10.1086/502477  0.34
2004 Maslow JN, Lautenbach E, Glaze T, Bilker W, Johnson JR. Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance. Antimicrobial Agents and Chemotherapy. 48: 3618-20. PMID 15328142 DOI: 10.1128/Aac.48.9.3618-3620.2004  0.36
2004 Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia Pediatric Infectious Disease Journal. 23: 635-641. PMID 15247602 DOI: 10.1097/01.Inf.0000128781.77600.6F  0.373
2004 Cerceo E, Christie JD, Nachamkin I, Lautenbach E. Central nervous system infections due to Abiotrophia and Granulicatella species: An emerging challenge? Diagnostic Microbiology and Infectious Disease. 48: 161-165. PMID 15023423 DOI: 10.1016/J.Diagmicrobio.2003.10.009  0.396
2004 Lautenbach E, Gould CV, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates International Journal of Antimicrobial Agents. 23: 200-203. PMID 15013047 DOI: 10.1016/J.Ijantimicag.2003.09.011  0.44
2004 Gould CV, Fishman NO, Nachamkin I, Lautenbach E. Chloramphenicol Resistance in Vancomycin-Resistant Enterococcal Bacteremia: Impact of Prior Fluoroquinolone Use? Infection Control and Hospital Epidemiology. 25: 138-145. PMID 14994940 DOI: 10.1086/502365  0.472
2004 Lautenbach E, Strom BL, Nachamkin I, Bilker WB, Marr AM, Larosa LA, Fishman NO. Longitudinal trends in fluoroquinolone resistance among enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: Differences in the emergence and epidemiology of resistance across organisms Clinical Infectious Diseases. 38: 655-662. PMID 14986249 DOI: 10.1086/381549  0.44
2003 Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. The New England Journal of Medicine. 349: 1628-35. PMID 14573734 DOI: 10.1056/Nejmoa022963  0.327
2003 Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of colonization with vancomycin-resistant enterococcus in patients awaiting liver transplantation American Journal of Transplantation. 3: 902-905. PMID 12814484 DOI: 10.1034/J.1600-6143.2003.00169.X  0.442
2003 McGovern PC, Lautenbach E, Brennan PJ, Lustig RA, Fishman NO. Risk factors for postcraniotomy surgical site infection after 1,3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement Clinical Infectious Diseases. 36: 759-765. PMID 12627360 DOI: 10.1086/368082  0.397
2003 Lautenbach E, Larosa LA, Kasbekar N, Peng HP, Maniglia RJ, Fishman NO. Fluoroquinolone utilization in the emergency departments of academic medical centers: Prevalence of, and risk factors for, inappropriate use Archives of Internal Medicine. 163: 601-605. PMID 12622607 DOI: 10.1001/Archinte.163.5.601  0.423
2003 Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: Impact of progressive restrictions on use of vancomycin and third-generation cephalosporins Clinical Infectious Diseases. 36: 440-446. PMID 12567301 DOI: 10.1086/346153  0.396
2002 Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections Archives of Internal Medicine. 162: 2469-2477. PMID 12437407 DOI: 10.1001/Archinte.162.21.2469  0.472
2002 Lautenbach E, Patel JB, Bilker WB, Fishman NO. Trends in antimicrobial susceptibility patterns among inpatient enterococcal isolates (1990 to 1999): Implications for therapeutic options [1] Infection Control and Hospital Epidemiology. 23: 416-418. PMID 12186203 DOI: 10.1086/503470  0.343
2002 Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species: Risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence Infection Control and Hospital Epidemiology. 23: 254-260. PMID 12026150 DOI: 10.1086/502045  0.423
2001 Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae Clinical Infectious Diseases. 33: 1288-1294. PMID 11565067 DOI: 10.1086/322667  0.502
2001 Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes Clinical Infectious Diseases. 32: 1162-1171. PMID 11283805 DOI: 10.1086/319757  0.454
1999 Lautenbach E, Fishman NO. Wagging the dog: Antibiotic use and the emergence of resistance Journal of General Internal Medicine. 14: 643-645. PMID 10571711 DOI: 10.1046/J.1525-1497.1999.07029.X  0.48
1999 Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality Infection Control and Hospital Epidemiology. 20: 318-323. PMID 10349947 DOI: 10.1086/501624  0.446
1999 Lautenbach E, Metlay JP. Managing upper respiratory tract infections practice without evidence Journal of General Internal Medicine. 14: 203-204. PMID 10203630 DOI: 10.1046/J.1525-1497.1999.00315.X  0.476
1998 Lautenbach E, Schuster MG, Bilker WB, Brennan PJ. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus Clinical Infectious Diseases. 27: 1259-1265. PMID 9827280 DOI: 10.1086/515002  0.376
1997 Lautenbach E, Brennan PJ. Vancomycin resistance and mortality associated with enterococcal bacteremia. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 24: 530-1. PMID 9114224 DOI: 10.1093/Clinids/24.3.530  0.373
1997 Lautenbach E, Bilker WB, Schuster MG, Brennan PJ. Chloramphenicol in the treatment of vancomycin-resistant enterococcal bacteremia Clinical Infectious Diseases. 25: 435.  0.314
Show low-probability matches.